Oceania Healthcare (ASX:OCA, NZE:OCA) said new sales volumes increased 29% and resales volumes rose 6% in the third quarter of the fiscal year compared with the prior-year period, according to Wednesday releases with the Australian and New Zealand bourses.
It is continuing to divest non-core sites and it is establishing a centralized team to support the delivery of long-term savings, expected to be in the range of NZ$10 million to NZ$15 million annually, reflecting the right sizing of support functions in light of divestments.
A NZ$5 million annualized cost right sizing program was completed and benefits from it are expected to be realized from fiscal 2026.
It also completed a refinance of debt facilities on Tuesday, March 4.
The firm's shares rose 6% in early trading on Wednesday on the New Zealand bourse and fell 2% on the Australian bourse.
Price (AUD): $0.60, Change: $-0.010, Percent Change: -1.64%